van Ravenhorst, Mariėtte B <br/><br/>
Adolescent meningococcal serogroup A, W and Y immune responses following immunization with quadrivalent meningococcal A, C, W and Y conjugate vaccine: Optimal age for vaccination.  [electronic resource] 

 -  Vaccine  08 2017 
 - 4753-4760 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase IV; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1873-2518 
<br/><br/><label>Standard No.: </label>10.1016/j.vaccine.2017.06.007  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Age Factors<br/>Animals<br/>Antibodies, Bacterial--blood<br/>Child<br/>Complement System Proteins<br/>Europe--epidemiology<br/>Female<br/>Humans<br/>Immunization, Secondary<br/>Immunoglobulin G--blood<br/>Incidence<br/>Male<br/>Meningococcal Infections--epidemiology<br/>Meningococcal Vaccines--immunology<br/>Neisseria meningitidis--immunology<br/>Neisseria meningitidis, Serogroup Y--immunology<br/>Netherlands--epidemiology<br/>Rabbits<br/>Serogroup<br/>Serum Bactericidal Antibody Assay<br/>Time Factors<br/>Vaccination--methods